Instil Bio (TIL) Total Liabilities (2020 - 2026)

Instil Bio has reported Total Liabilities for 7 years, with the latest figure at $90.3 million in Q2 2026.

• On a quarterly basis, Total Liabilities fell 9.05% year-over-year to $90.3 million in Q2 2026; TTM through Jun 2026 was $90.3 million, a 9.05% decrease from a year earlier, with the FY2025 full-year figure at $89.7 million, down 4.75% from the prior year.
• Total Liabilities was $90.3 million for Q2 2026 at Instil Bio, up from $89.7 million in the prior quarter.
• The five-year high for Total Liabilities was $122.2 million in Q3 2022, with the low at $56.4 million in Q1 2022.
• Average Total Liabilities over 5 years is $99.1 million, with a median of $99.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities surged 196.26% in 2022, then retreated 15.8% in 2023.
• Over 5 years, Total Liabilities stood at $118.5 million in 2022, then dropped by 15.8% to $99.8 million in 2023, then fell by 5.68% to $94.1 million in 2024, then retreated by 4.75% to $89.7 million in 2025, then gained by 0.75% to $90.3 million in 2026.
• The last three Total Liabilities figures came in at $90.3 million (Q2 2026), $89.7 million (Q1 2026), and $89.7 million (Q4 2025), per Business Quant data.